OTT-5852-epigenetic-approaches-in-the-treatment-of-myelodysplastic-sy

First Page		Document Content
Triazines Orphan drugs Azacitidine lactams Demethylating agent Decitabine Myelodysplastic syndrome Hypomethylating agent Lenalidomide Medicine Oncology Nucleosides		OTT-5852-epigenetic-approaches-in-the-treatment-of-myelodysplastic-sy Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 174,16 KB Share Document on Facebook

	Lifebank_Logo_withTag-centered DocID: 1rakV - View Document
	NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript DocID: 1qxR7 - View Document
	Microsoft Word - blood_cancer_gene_sanger_institute_release DocID: 1qeRh - View Document
	Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016 DocID: 1pn6V - View Document
	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid DocID: 1oCtU - View Document